{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:28:29Z","timestamp":1770535709149,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of Istanbul University"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.leukres.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T14:42:59Z","timestamp":1560004979000},"page":"106159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prognostic gene alterations and clonal changes in childhood B-ALL"],"prefix":"10.1016","volume":"83","author":[{"given":"Yucel","family":"Erbilgin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Firtina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevcan","family":"Mercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozden","family":"Hatirnaz Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orcun","family":"Tasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Karakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin Tiraje","family":"Celkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazan","family":"Sarper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep Yildiz","family":"Yildirmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Sisko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muge","family":"Sayitoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2019.05.009_bib0005","article-title":"Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing","author":"Ishida","year":"2018","journal-title":"Ann. Hematol."},{"issue":"16","key":"10.1016\/j.leukres.2019.05.009_bib0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.leukres.2019.05.009_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S2352-4642(18)30066-X","article-title":"Global efforts toward the cure of childhood acute lymphoblastic leukaemia","volume":"2","author":"Pui","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.leukres.2019.05.009_bib0020","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1200\/EDBK_156628","article-title":"Advances in the genetics and therapy of acute lymphoblastic leukemia","volume":"35","author":"Chiaretti","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"6","key":"10.1016\/j.leukres.2019.05.009_bib0025","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2019.05.009_bib0030","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.leukres.2019.05.009_bib0035","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","article-title":"Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia","volume":"120","author":"Faham","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2019.05.009_bib0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2019.05.009_bib0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.seminhematol.2013.10.001","article-title":"Genomic characterization of childhood acute lymphoblastic leukemia","volume":"50","author":"Mullighan","year":"2013","journal-title":"Semin. Hematol."},{"issue":"26","key":"10.1016\/j.leukres.2019.05.009_bib0050","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2019.05.009_bib0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1084\/jem.20160048","article-title":"Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome","volume":"214","author":"Witkowski","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.leukres.2019.05.009_bib0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1","article-title":"Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse\u2013the Children\u2019s Cancer group Experience","volume":"82","author":"Gaynon","year":"1998","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.leukres.2019.05.009_bib0065","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"issue":"5906","key":"10.1016\/j.leukres.2019.05.009_bib0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.leukres.2019.05.009_bib0075","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","article-title":"Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia","volume":"6","author":"Ma","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.leukres.2019.05.009_bib0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/bloodadvances.2018025718","article-title":"Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL","volume":"3","author":"Hamadeh","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2019.05.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cy0501s73","article-title":"Collection, storage, and preparation of human blood cells","volume":"73","author":"Dagur","year":"2015","journal-title":"Curr. Protoc. Cytom."},{"issue":"4","key":"10.1016\/j.leukres.2019.05.009_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.leukres.2019.05.009_bib0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.leukres.2019.05.009_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.leukres.2019.05.009_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.leukres.2011.07.017","article-title":"Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia","volume":"36","author":"Firtina","year":"2012","journal-title":"Leuk. Res."},{"issue":"7137","key":"10.1016\/j.leukres.2019.05.009_bib0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.leukres.2019.05.009_bib0115","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2404691","article-title":"High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression","volume":"21","author":"Kuiper","year":"2007","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2019.05.009_bib0120","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat. Genet."},{"issue":"7037","key":"10.1016\/j.leukres.2019.05.009_bib0125","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.leukres.2019.05.009_bib0130","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.leukres.2019.05.009_bib0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/bjc.2017.152","article-title":"Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia","volume":"117","author":"Forero-Castro","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"52","key":"10.1016\/j.leukres.2019.05.009_bib0140","doi-asserted-by":"crossref","first-page":"89923","DOI":"10.18632\/oncotarget.21027","article-title":"Aberrations in childhood B-cell precursor acute lymphoblastic leukemia","volume":"8","author":"Steeghs","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2019.05.009_bib0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijbiomac.2013.05.029","article-title":"The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stability","volume":"60","author":"Li","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.leukres.2019.05.009_bib0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.beha.2011.09.004","article-title":"Genomic profiling of B-progenitor acute lymphoblastic leukemia","volume":"24","author":"Mullighan","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"11","key":"10.1016\/j.leukres.2019.05.009_bib0155","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2019.05.009_bib0160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.leukres.2019.05.009_bib0165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2013.085175","article-title":"Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features","volume":"98","author":"Schwab","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2019.05.009_bib0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/leu.2012.155","article-title":"Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia","volume":"27","author":"Krentz","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2019.05.009_bib0175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V97.2.572","article-title":"Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse","volume":"97","author":"Carter","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2019.05.009_bib0180","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1182\/blood.V99.12.4629","article-title":"Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia","volume":"99","author":"Graf Einsiedel","year":"2002","journal-title":"Blood"},{"issue":"7\u20138","key":"10.1016\/j.leukres.2019.05.009_bib0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/08880018.2016.1251518","article-title":"The role of CDKN2A\/B deletions in pediatric acute lymphoblastic leukemia","volume":"33","author":"Carrasco Salas","year":"2016","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2019.05.009_bib0190","first-page":"1","article-title":"Deletion of CDKN2A\/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia","author":"Kathiravan","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.leukres.2019.05.009_bib0195","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2403769","article-title":"CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia","volume":"19","author":"van Zutven","year":"2005","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2019.05.009_bib0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10428194.2016.1193855","article-title":"Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia","volume":"58","author":"Gupta","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.leukres.2019.05.009_bib0205","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/gcc.22486","article-title":"Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms","volume":"56","author":"Ribera","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2019.05.009_bib0210","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/10428194.2016.1228925","article-title":"Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia","volume":"58","author":"Braun","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"13","key":"10.1016\/j.leukres.2019.05.009_bib0215","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.leukres.2019.05.009_bib0220","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2019.05.009_bib0225","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/gcc.22190","article-title":"An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression","volume":"53","author":"Yano","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"15","key":"10.1016\/j.leukres.2019.05.009_bib0230","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","article-title":"Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2019.05.009_bib0235","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26539","article-title":"Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood","volume":"64","author":"Schm\u00e4h","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"7","key":"10.1016\/j.leukres.2019.05.009_bib0240","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/leu.2016.365","article-title":"Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia","volume":"31","author":"Vesely","year":"2017","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619300979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619300979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T23:58:39Z","timestamp":1608249519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212619300979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":48,"alternative-id":["S0145212619300979"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2019.05.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic gene alterations and clonal changes in childhood B-ALL","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106159"}}